Lunch with Dana Foss, Co-founder & CEO of Editpep

​Join Dana Foss, CEO and co-founder of Editpep, who's taking on diseases that have been off-limits for traditional therapies. Dana built Editpep to crack open some of medicine's toughest challenges—rare genetic disorders and complex conditions where precision gene editing could fundamentally change outcomes. The platform combines novel editing mechanisms with peptide therapeutics to make previously "undruggable" targets actually treatable.

​Come listen to what it's like building a biotech from scratch in one of the most technically ambitious corners of life sciences. The lab breakthroughs that matter, the fundraising realities, navigating regulatory pathways, and finding the right talent. Whether you're thinking about gene editing startups, curious about the business of precision medicine, or just want real talk about hard tech entrepreneurship over lunch in Berkeley, don't miss this one.

This is a 10-person lunch in Berkeley hosted by The Yale Table. Real questions, real answers, good food.

​​Selected participants will be asked to contribute a fee covering part of the lunch expenses.